Archives
Press Releases
advertisement
February 21, 2018
- Insulet Has Strong Presence at the International ATTD Congress; Presents Positive Study Results for Its Omnipod Horizon™ Hybrid Closed-Loop System.
- Reduced Time in Hypoglycemia Demonstrated in Tandem Diabetes Care’s Pivotal Trial for the t:slim X2 Insulin Pump with Predictive Low Glucose Suspend Feature; Data to be Presented at ATTD 2018 Conference.
- New Study Demonstrates that DexCom CGM Significantly Reduces Hypoglycaemia in People with Type 1 Diabetes on MDI.
- Tandem Diabetes Care Applies for Health Canada Medical Device License.
- Tackling the Cell Supply Challenge Takes Center Stage in Spain as DRI’s Dr. Juan Dominguez-Bendala Discusses Potential Breakthroughs.
- Zealand Pharma’s dasiglucagon Phase 2a results at the 11th International Conference on ATTD.
January 10, 2018
- Tandem Diabetes Care Reports Successful Completion of First Pilot Study Using t:slim X2 Insulin Pump with TypeZero Hybrid Closed Loop Technology and Dexcom G6 Integration; Confirms IDCL Multi-site Study Timeline.
- Abbott’s Revolutionary Continuous Glucose Monitoring System, FreeStyle® Libre, Now Available To Medicare Patients.
- Livongo and Lilly Collaborate on Real-World Diabetes Research.
advertisement
